ContraFect’s $52.5 Million Public Offering And $3 Million Private Placement

Ambrogio Visconti

Latham & Watkins LLP represents ContraFect Corporation in the transactions. ContraFect Corporation, a clinical-stage biotechnology company focused on discovering and developing direct lytic agents for the…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now